|
|
||||||||||
|
J Am Coll Cardiol, 2006; 47:1663-1671, doi:10.1016/j.jacc.2005.11.070
(Published online 24 March 2006). © 2006 by the American College of Cardiology Foundation |
,



,
,*
* Ospedale Multimedica, Milan, Italy
Heart and Great Vessels Department "Attilio Reale," "La Sapienza" University, Rome, Italy
National Institute for Infectious Diseases "Lazzaro Spallanzani," Rome, Italy
Radiology Department, San Raffaele Hospital, Milan, Italy
|| Pathology Department, "La Sapienza" University, Rome, Italy
¶ "San Raffaele Pisana" Institute, Rome, Italy
Manuscript received October 4, 2005; revised manuscript received November 1, 2005, accepted November 22, 2005.
* Reprint requests and correspondence: Dr. Andrea Frustaci, The Heart and Great Vessels Department "Attilio Reale," La Sapienza University, viale del Policlinico 155, 00100 Rome, Italy. (Email: biocard{at}rm.unicatt.it).
OBJECTIVES: We sought to identify echocardiographic hallmarks of Fabrys disease cardiomyopathy (FC).
BACKGROUND: The recognition of FC from other forms of left ventricular hypertrophy (LVH) by noninvasive imaging techniques is not yet available, and diagnosis, mostly in the absence of systemic manifestations, still relies on genetic and invasive studies.
METHODS: Forty consecutive patients (mean age 39 ± 15 years, 22 men and 18 women) with an established diagnosis of Fabrys disease were submitted to echocardiographic evaluation. Control population consisted of 40 consecutive patients with hypertrophic cardiomyopathy (HCM), 40 hypertensive patients with echocardiographic evidence of LVH, and 40 age- and gender-matched healthy subjects with no LVH. All HCM patients and FC with LVH and/or cardiac symptoms underwent cardiac catheterization with left ventricular endomyocardial biopsy.
RESULTS: Echocardiography showed in 83% of FC patients (95% of FC patients with LVH) a binary appearance of endocardial border absent in all HCM, hypertensive, and healthy subjects. The sensitivity and specificity of this echocardiographic feature in detecting Fabry patients in study population were 94% and 100%, respectively. Comparison of echocardiographic with histologic and ultrastructural findings showed the binary appearance to reflect an endomyocardial glycosphingolipids compartmentalization, consisting of thickened glycolipid-rich endocardium, free glycosphingolipid subendocardial storage, and an inner severely affected myocardial layer with a clear subendocardial-midwall layer gradient of disease severity.
CONCLUSIONS: Echocardiographic binary appearance of left ventricular endocardial border, reflecting endomyocardial glycosphingolipids compartmentalization, represents a sensitive and specific diagnostic hallmark of Fabrys disease cardiomyopathy.
| |||||||
This article has been cited by other articles:
![]() |
S. B. Joshi, W. Ahmar, G. Lee, and A. Aggarwal Fabry's disease presenting as ventricular tachycardia and Left Ventricular 'Hypertrophy' Eur J Echocardiogr, September 1, 2008; 9(5): 697 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Schoenmakere, B. Poppe, B. Wuyts, K. Claes, D. Cassiman, B. Maes, D. Verbeelen, R. Vanholder, D. R. Kuypers, N. Lameire, et al. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients Nephrol. Dial. Transplant., July 2, 2008; (2008) gfn370v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chimenti, N. Hamdani, N. M. Boontje, F. DeCobelli, A. Esposito, J. G.F. Bronzwaer, G. J.M. Stienen, M. A. Russo, W. J. Paulus, A. Frustaci, et al. Myofilament Degradation and Dysfunction of Human Cardiomyocytes in Fabry Disease Am. J. Pathol., June 1, 2008; 172(6): 1482 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kounas, C. Demetrescu, A. A. Pantazis, A. Keren, P. J. Lee, D. Hughes, A. Mehta, and P. M. Elliott The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2058 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kovacevic-Preradovic, M. Zuber, C.H. Attenhofer Jost, U. Widmer, B. Seifert, G. Schulthess, A. Fischer, and R. Jenni Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy Eur J Echocardiogr, April 14, 2008; (2008) jen129v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pieroni, F. Bellocci, and F. Crea Letter by Pieroni et al Regarding Article, "Contrast-Enhanced Magnetic Resonance Imaging of a Patient With Chloroquine-Induced Cardiomyopathy Confirmed by Endomyocardial Biopsy" Circulation, February 6, 2007; 115(5): e67 - e67. [Full Text] [PDF] |
||||
![]() |
T. Reffelmann, H. P. Kuhl, A. Naami, and E. Spuentrup Response to Letter Regarding Article, "Contrast-Enhanced Magnetic Resonance Imaging of a Patient With Chloroquine-Induced Cardiomyopathy Confirmed by Endomyocardial Biopsy" Circulation, February 6, 2007; 115(5): e68 - e68. [Full Text] [PDF] |
||||
![]() |
S. F. Nagueh and J. J. Mahmarian Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2410 - 2422. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |